Blog Archives - Catalyst Regenerative Network
189
archive,category,category-blog,category-189,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Blog

The test for identifying potential APIC-A2M candidates is the Fibronectin-Aggrecan Complex Test, or FACT. This complimentary diagnostic molecular biomarker test is performed only by Cytonics and is used to identify symptomatic intervertebral discs or painful joint abnormalities. FACT measures the presence of the Fibronectin-Aggrecan Complex (FAC) from a third of a cc fluid specimen taken from a patient. FAC is a...

It’s always exciting at The Orthobiologic Institute’s (TOBI) annual event and the 2018 Symposium was no different. Expert thought leaders presented compelling research and advancements that can benefit everyone in the regenerative medicine space. We put together the top 10 quotes from a few of this year’s featured speakers who are at the forefront of the regenerative charge. 10. “Cell-based therapies, outside...

Dr. Andrew Konen specializes in pain management at his Dallas, TX practice, Konen & Associates. In 2016, Dr. Konen started using regenerative therapies to provide patients more long-lasting and, hopefully, permanent relief of difficult to diagnose chronic headache conditions. "Most colleagues thought I was nuts, even my own partners. Many of these patients had multiple decades long chronic daily head pain which we...

With the rapid advances occurring in the Regenerative Medicine space, it can be difficult to decipher which are quality products and not an imitation, promising sub par results. There is only one system on the market that ISOLATES and CONCENTRATES Alpha-2-Macroglobulin (A2M), and that is the Cytonics APIC-A2M System. While any blood-based system will include trace amounts of A2M, it will not deliver A2M...